AKT1 and idiopathic pulmonary fibrosis: The treatment with this peptide was able to alter the accumulation of Akt1, which is a protein highly expressed in the lungs of patients with IPF and which is related to cell survival by mediating growth, metabolism, and ROS production, as well as the regulation of TNF- α [63,64,69].